Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
Avon Foundation
Information provided by (Responsible Party):
Northwestern University
ClinicalTrials.gov Identifier:
NCT00983424
First received: September 22, 2009
Last updated: September 13, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)